期刊文献+

多奈哌齐联合胞磷胆碱注射液治疗阿尔茨海默症的临床效果及对患者血清炎性因子水平的影响 被引量:1

Clinical effect of donepezil combined with citicoline injection in the treatment of Alzheimer's disease and its influence on serum inflammatory factors levels of patients
下载PDF
导出
摘要 目的探究多奈哌齐联合胞磷胆碱注射液治疗阿尔茨海默症(AD)的临床效果。方法依据单双号将110例AD患者分为对照组(n=55)和研究组(n=55)。对照组给予胞磷胆碱注射液治疗,研究组在对照组的基础上联合多奈哌齐治疗。比较两组患者的治疗效果。结果研究组的治疗总有效率显著高于对照组(P<0.05)。治疗后,两组的IL-6、IL-1β、CRP及TNF-α水平均降低,且研究组低于对照组(P<0.05)。治疗后,两组的记忆力、注意力和计算力、回忆力评分均升高,且研究组高于对照组(P<0.05)。研究组的日常生活能力优良率高于对照组(P<0.05)。结论多奈哌齐联合胞磷胆碱注射液治疗AD效果显著,能够调节患者血清炎性因子水平,改善认知功能及日常生活能力,且用药安全性较高。 Objective To explore the clinical effect of donepezil combined with citicoline injection in the treatment of Alzheimer's disease(AD).Methods According to odd and even numbers,110 AD patients were divided into control group(n=55)and study group(n=55).The control group was treated with cyticoline injection,and the study group was treated with donepezil on the basis of the control group.The therapeutic effects of the two groups were compared.Results The total effective rate of treatment in the study group was significantly higher than that in the control group(P<0.05).After treatment,the levels of IL-6,IL-1β,CRP and TNF-α in both groups decreased,and those in the study group were lower than the control group(P<0.05).After treatment,the scores of memory,attention and computation and recall in both groups increased,and those in the study group were higher than the control group(P<0.05).The excellent and good rate of activity of daily living in the study group was higher than that in the control group(P<0.05).Conclusion Donepezil combined with citicoline injection is effective in the treatment of AD,which can regulate the level of serum inflammatory factors,improve cognitive function and ability of daily living,with high safety.
作者 乔娜娜 邵贺 QIAO Nana;SHAO He(Xianyang Hospital of Yan'an University,Xianyang 712000,China)
出处 《临床医学研究与实践》 2021年第29期68-70,共3页 Clinical Research and Practice
关键词 多奈哌齐 胞磷胆碱注射液 阿尔茨海默症 血清炎性因子 donepezil citicoline injection Alzheimer's disease serum inflammatory factors
  • 相关文献

参考文献10

二级参考文献69

  • 1沈渔村,李格,李淑然,陈昌惠,赵友文,刘棉.北京市城区老年期痴呆三年随访研究[J].中国心理卫生杂志,1994,8(4):165-166. 被引量:25
  • 2李格,沈渔邨,陈昌惠,李淑然,张维熙,刘棉.简易精神状态检查表在不同人群中的试测研究[J].中国心理卫生杂志,1989,3(4):148-151. 被引量:93
  • 3董永成,陈永顺,杜士明,黄良永.抗老年痴呆症药物的应用及研究进展[J].中国药房,2006,17(15):1185-1187. 被引量:8
  • 4Burns A, Rossor M, Hecker J, et al. The effects of donepezil in Alzheimer's disease - results from a multinational trial.Dement Geriatr Cogn Disord, 1999,10(3):237-44.
  • 5Small G, Erkinjuntti T, Kurz A, et al. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.CNS Drugs, 2003,17(12):905-14.
  • 6Farlow M, Potkin S, Koumaras B, et al. Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo,26-week, Alzheimer disease trial. Arch Neurol, 2003,60(6):843-8.
  • 7Doody RS, Geldmacher DS, Gordon B, et al. Open-label,multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol,2001,58(3):427-33.
  • 8McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology,1984.34(7):939-44.
  • 9Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr, 1997,9 Suppl 1:173-6; discussion 177-8.
  • 10Liu HC, Teng EL, Chuang YY, et al. The Alzheimer's Disease Assessment Scale: findings from a low-education population.Dement Geriatr Cogn Disord, 2002,13(1):21-6.

共引文献189

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部